Pentraxin-3 predicts functional recovery and 1-year major adverse cardiovascular events after rehabilitation of cardiac surgery patients.
Ferratini M, Ripamonti V, Masson S, Grati P, Racca V, Cuccovillo I, Raimondi E, Capomolla S, Macchi C, Coruzzi P, Vago T, Calvo M, Mantovani A, Latini R.
Ferratini M, et al. Among authors: racca v.
J Cardiopulm Rehabil Prev. 2012 Jan-Feb;32(1):17-24. doi: 10.1097/HCR.0b013e31823be0f4.
J Cardiopulm Rehabil Prev. 2012.
PMID: 22193930